491 related articles for article (PubMed ID: 17097393)
1. Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis: a clinicopathologic and immunohistochemical study.
Soares Almeida LM; Requena L; Kutzner H; Angulo J; de Sa J; Pignatelli J
J Am Acad Dermatol; 2006 Dec; 55(6):968-74. PubMed ID: 17097393
[TBL] [Abstract][Full Text] [Related]
2. Vasculitis in erythema induratum of Bazin: a histopathologic study of 101 biopsy specimens from 86 patients.
Segura S; Pujol RM; Trindade F; Requena L
J Am Acad Dermatol; 2008 Nov; 59(5):839-51. PubMed ID: 19119100
[TBL] [Abstract][Full Text] [Related]
3. Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. A report of two cases.
Ball NJ; Cowan BJ; Moore GR; Hashimoto SA
J Cutan Pathol; 2008 Apr; 35(4):407-10. PubMed ID: 18333902
[TBL] [Abstract][Full Text] [Related]
4. Endermology: a treatment for injection-induced lipoatrophy in multiple sclerosis patients treated with sub cutaneous glatiramer acetate.
Lebrun C; Mondot L; Bertagna M; Calleja A; Cohen M
Clin Neurol Neurosurg; 2011 Nov; 113(9):721-4. PubMed ID: 21839580
[TBL] [Abstract][Full Text] [Related]
5. Localized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate (Copaxone) injection for the treatment of multiple sclerosis.
Soós N; Shakery K; Mrowietz U
Am J Clin Dermatol; 2004; 5(5):357-9. PubMed ID: 15554737
[TBL] [Abstract][Full Text] [Related]
6. Contribution of endermology to improving indurations and panniculitis/lipoatrophy at glatiramer acetate injection site.
Rubio Fernández D; Rodríguez Del Canto C; Marcos Galán V; Falcón N; Edreira H; Sevane Fernández L; Francoli Martínez P; Sánchez-De la Rosa R
Adv Ther; 2012 Mar; 29(3):267-75. PubMed ID: 22382874
[TBL] [Abstract][Full Text] [Related]
7. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.
Ball NJ; Cowan BJ; Hashimoto SA
J Cutan Pathol; 2009 Mar; 36(3):331-7. PubMed ID: 19032383
[TBL] [Abstract][Full Text] [Related]
8. Necrotizing skin lesions with involvement of muscle tissue after subcutaneous injection of glatiramer acetate.
Feldmann R; Schierl M; Rauschka H; Sator PG; Breier F; Steiner A
Eur J Dermatol; 2009; 19(4):385. PubMed ID: 19451051
[No Abstract] [Full Text] [Related]
9. Normal subcutaneous fat, necrosis of adipocytes and classification of the panniculitides.
Requena L
Semin Cutan Med Surg; 2007 Jun; 26(2):66-70. PubMed ID: 17544956
[TBL] [Abstract][Full Text] [Related]
10. Panniculitis. Part I. Mostly septal panniculitis.
Requena L; Yus ES
J Am Acad Dermatol; 2001 Aug; 45(2):163-83; quiz 184-6. PubMed ID: 11464178
[TBL] [Abstract][Full Text] [Related]
11. Embolia cutis medicamentosa following subcutaneous injection of glatiramer acetate.
Harde V; Schwarz T
J Dtsch Dermatol Ges; 2007 Dec; 5(12):1122-3. PubMed ID: 18042092
[TBL] [Abstract][Full Text] [Related]
12. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma.
Lozzi GP; Massone C; Citarella L; Kerl H; Cerroni L
Am J Dermatopathol; 2006 Feb; 28(1):9-12. PubMed ID: 16456318
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal shock wave therapy for injection site panniculitis in multiple sclerosis patients.
Stieger M; Schmid JP; Yawalkar N; Hunziker T
Dermatology; 2015; 230(1):82-6. PubMed ID: 25502016
[TBL] [Abstract][Full Text] [Related]
14. Postirradiation pseudosclerodermatous panniculitis: three new cases with additional histopathologic features supporting the radiotherapy etiology.
Pielasinski U; Machan S; Camacho D; Juárez A; Cedeño M; Maciá JA; Requena L
Am J Dermatopathol; 2013 Feb; 35(1):129-34. PubMed ID: 23038023
[TBL] [Abstract][Full Text] [Related]
15. Glatiramer acetate: successful desensitization for treatment of multiple sclerosis.
Bains SN; Hsieh FH; Rensel MR; Radojicic C; Katz HT; Inamdar SR; Lang DM
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):321-5. PubMed ID: 20408342
[TBL] [Abstract][Full Text] [Related]
16. Immunological mechanisms underlying delayed-type hypersensitivity reactions to glatiramer acetate.
Mayorga C; Blazquez AB; Doña I; Gomez F; Chaves P; Sanchez-Quintero MJ; Blanca-López N; Melendez L; Blanca M; Torres MJ
Ann Allergy Asthma Immunol; 2012 Jul; 109(1):47-51. PubMed ID: 22727157
[TBL] [Abstract][Full Text] [Related]
17. [Rare and clinically relevant adverse reactions following subcutaneous administration of glatiramer acetate].
Sevilla Ortiz M; Martínez Martínez L; Piñeiro Corrales G
Farm Hosp; 2011; 35(3):160-1. PubMed ID: 21441052
[No Abstract] [Full Text] [Related]
18. [Long-term effects of glatiramer acetate in multiple sclerosis].
Brochet B
Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
[TBL] [Abstract][Full Text] [Related]
19. Fat tissue after lipolysis of lipomas: a histopathological and immunohistochemical study.
Bechara FG; Sand M; Hoffmann K; Sand D; Altmeyer P; Stücker M
J Cutan Pathol; 2007 Jul; 34(7):552-7. PubMed ID: 17576334
[TBL] [Abstract][Full Text] [Related]
20. Systemic reaction to glatiramer acetate.
Bayerl C; Bohland P; Jung EG
Contact Dermatitis; 2000 Jul; 43(1):62-3. PubMed ID: 10902605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
